Compare DERM & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DERM | FOA |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 221.6M |
| IPO Year | 2021 | 2021 |
| Metric | DERM | FOA |
|---|---|---|
| Price | $6.15 | $14.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $12.67 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 156.5K | 57.2K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.72 | ★ 216.95 |
| EPS | N/A | ★ 0.41 |
| Revenue | $61,858,000.00 | ★ $497,432,000.00 |
| Revenue This Year | $39.72 | $0.58 |
| Revenue Next Year | $63.24 | $6.91 |
| P/E Ratio | ★ N/A | $35.10 |
| Revenue Growth | 10.20 | ★ 47.09 |
| 52 Week Low | $4.31 | $13.73 |
| 52 Week High | $9.56 | $29.79 |
| Indicator | DERM | FOA |
|---|---|---|
| Relative Strength Index (RSI) | 32.17 | 28.72 |
| Support Level | $5.92 | N/A |
| Resistance Level | $6.59 | $20.17 |
| Average True Range (ATR) | 0.43 | 0.63 |
| MACD | -0.17 | 0.12 |
| Stochastic Oscillator | 0.53 | 22.96 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Finance of America Companies Inc provides home equity-based financing solutions for modern retirement and offers capital markets and portfolio management capabilities to optimize loan distribution to investors. The Company operates through two segments: Retirement Solutions and Portfolio Management. The Retirement Solutions segment handles loan origination, including HECM and non-agency reverse mortgage loans, generating revenue from origination fees and initial gains, with loans transferred to the Portfolio Management segment. The Portfolio Management segment, which generates the majority of revenue, provides securitization, loan sales, risk management, and asset management services, and earns revenue from net interest income, fair value changes, and servicing-related income.